Te-Sheng Chang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Topics

Hepatitis C Virus

Colorectal Cancer Screening

Helicobacter Pylori Infection

Top Venues

Diagnostics (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Chun-Hsien Chen, Yung-Yu Hsieh, Wei-Ming Chen, Chien-Heng Shen, Kuo-Liang Wei, Kao-Chi Chang, Yuan-Jie Ding, Sheng-Nan Lu, Chao-Hung Hung, Te-Sheng Chang
Weight Gain and Increased Body Mass Index in Patients with Hepatitis C after Eradication Using Direct-Acting Antiviral Therapy in Taiwan. Diagnostics (Basel, Switzerland) 14 (2) (2024)
Chun-Hsien Chen, Yung-Yu Hsieh, Wei-Ming Chen, Chien-Heng Shen, Kuo-Liang Wei, Kao-Chi Chang, Yuan-Jie Ding, Sheng-Nan Lu, Chao-Hung Hung, Te-Sheng Chang
Weight Gain and Increased Body Mass Index in Patients with Hepatitis C after Eradication Using Direct-Acting Antiviral Therapy in Taiwan. Diagnostics (Basel, Switzerland) 14 (2) (2024)
Syue-Wei Peng, Mai-Huong T Ngo, Yung-Che Kuo, Ming-Hao Teng, Chin-Lin Guo, Hung-Cheng Lai, Te-Sheng Chang, Yen-Hua Huang
Niclosamide Revitalizes Sorafenib through Insulin-like Growth Factor 1 Receptor (IGF-1R)/Stemness and Metabolic Changes in Hepatocellular Carcinoma. Cancers 15 (3) (2023)
Wei-Ru Cho, Hui-Ling Huang, Nien-Tzu Hsu, Tung-Jung Huang, Te-Sheng Chang
Above-Standard Survival of Hepatocellular Carcinoma as the Final Outcome of Comprehensive Hepatology Care Programs in a Remote HCV-Endemic Area. Viruses 15 (3) (2023)
Yung-Yu Hsieh, Wei-Ming Chen, Kao-Chi Chang, Te-Sheng Chang, Chao-Hung Hung, Yao-Hsu Yang, Shui-Yi Tung, Kuo-Liang Wei, Chen-Heng Shen, Cheng-Shyong Wu, Yuan-Jie Ding, Jing-Hong Hu, Yu-Ting Huang, Meng-Hung Lin, Chung-Kuang Lu, Yi-Hsiung Lin, Ming-Shyan Lin
Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver Cirrhosis. Viruses 15 (1) (2023)
Chun-Hsien Chen, Chien-Heng Shen, Kuo-Liang Wei, Huang-Wei Xu, Wei-Ming Chen, Kao-Chi Chang, Yu-Ting Huang, Yung-Yu Hsieh, Sheng-Nan Lu, Chao-Hung Hung, Te-Sheng Chang
Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy. Diagnostics (Basel, Switzerland) 13 (3) (2023)
Yung-Yu Hsieh, Wei-Ming Chen, Kao-Chi Chang, Te-Sheng Chang, Chao-Hung Hung, Yao-Hsu Yang, Shui-Yi Tung, Kuo-Liang Wei, Chen-Heng Shen, Cheng-Shyong Wu, Yuan-Jie Ding, Jing-Hong Hu, Yu-Ting Huang, Meng-Hung Lin, Chung-Kuang Lu, Yi-Hsiung Lin, Ming-Shyan Lin
Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver Cirrhosis. Viruses 15 (1) (2023)
Yung-Yu Hsieh, Wei-Ming Chen, Kao-Chi Chang, Te-Sheng Chang, Chao-Hung Hung, Yao-Hsu Yang, Shui-Yi Tung, Kuo-Liang Wei, Chen-Heng Shen, Cheng-Shyong Wu, Yuan-Jie Ding, Jing-Hong Hu, Yu-Ting Huang, Meng-Hung Lin, Chung-Kuang Lu, Yi-Hsiung Lin, Ming-Shyan Lin
Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver Cirrhosis. Viruses 15 (1) (2023)
Syue-Wei Peng, Mai-Huong T Ngo, Yung-Che Kuo, Ming-Hao Teng, Chin-Lin Guo, Hung-Cheng Lai, Te-Sheng Chang, Yen-Hua Huang
Niclosamide Revitalizes Sorafenib through Insulin-like Growth Factor 1 Receptor (IGF-1R)/Stemness and Metabolic Changes in Hepatocellular Carcinoma. Cancers 15 (3) (2023)
Yung-Yu Hsieh, Wei-Ming Chen, Kao-Chi Chang, Te-Sheng Chang, Chao-Hung Hung, Yao-Hsu Yang, Shui-Yi Tung, Kuo-Liang Wei, Chen-Heng Shen, Cheng-Shyong Wu, Yuan-Jie Ding, Jing-Hong Hu, Yu-Ting Huang, Meng-Hung Lin, Chung-Kuang Lu, Yi-Hsiung Lin, Ming-Shyan Lin
Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver Cirrhosis. Viruses 15 (1) (2023)
Chun-Hsien Chen, Chien-Heng Shen, Kuo-Liang Wei, Huang-Wei Xu, Wei-Ming Chen, Kao-Chi Chang, Yu-Ting Huang, Yung-Yu Hsieh, Sheng-Nan Lu, Chao-Hung Hung, Te-Sheng Chang
Factors Associated with Large Renal Function Decline in Patients with Chronic Hepatitis C Successfully Treated with Direct-Acting Antiviral Therapy. Diagnostics (Basel, Switzerland) 13 (3) (2023)
Wei-Ru Cho, Hui-Ling Huang, Nien-Tzu Hsu, Tung-Jung Huang, Te-Sheng Chang
Above-Standard Survival of Hepatocellular Carcinoma as the Final Outcome of Comprehensive Hepatology Care Programs in a Remote HCV-Endemic Area. Viruses 15 (3) (2023)
Wei-Ru Cho, Hui-Ling Huang, Nien-Tzu Hsu, Tung-Jung Huang, Te-Sheng Chang
Above-Standard Survival of Hepatocellular Carcinoma as the Final Outcome of Comprehensive Hepatology Care Programs in a Remote HCV-Endemic Area. Viruses 15 (3) (2023)
Yen-Chun Chen, Te-Sheng Chang, Chien-Hung Chen, Pin-Nan Cheng, Ching-Chu Lo, Lein-Ray Mo, Chun-Ting Chen, Chung-Feng Huang, Hsing-Tao Kuo, Yi-Hsiang Huang, Chi-Ming Tai, Cheng-Yuan Peng, Ming-Jong Bair, Ming-Lun Yeh, Chih-Lang Lin, Yung-Chang Lin, Pei-Lun Lee, Lee-Won Chong, Chao-Hung Hung, Jee-Fu Huang, Chi-Chieh Yang, Jui-Ting Hu, Chih-Wen Lin, Chia-Chi Wang, Wei-Wen Su, Tsai-Yuan Hsieh, Chih-Lin Lin, Wei-Lun Tsai, Tzong-Hsi Lee, Guei-Ying Chen, Szu-Jen Wang, Chun-Chao Chang, Sheng-Shun Yang, Wen-Chih Wu, Chia-Sheng Huang, Chou-Kwok Hsiung, Chien-Neng Kao, Pei-Chien Tsai, Chen-Hua Liu, Mei-Hsuan Lee, Chia-Yen Dai, Jia-Horng Kao, Wan-Long Chuang, Han-Chieh Lin, Chi-Yi Chen, Kuo-Chih Tseng, Ming-Lung Yu, null On Behalf Of Tacr Investigators
Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals. Viruses 14 (2) (2022)
Cheng-Kun Wu, Li-Wei Chen, Te-Sheng Chang, Shui-Yi Tung, Yung-Chang Lin, Chao-Hung Hung, Sheng-Nan Lu, Chih-Lang Lin, Chien-Hung Chen, Chao-Wei Hsu, Tsung-Hui Hu, I-Shyan Sheen
The Novel Finding of Dynamic Change in eGFR Up to One Year after End of Treatment in HCV-Infected Patients Receiving Sofosbuvir and Velpatasvir. Viruses 14 (2) (2022)
Wei-Cheng Huang, Yu-Chen Lin, Po-Ju Chen, Nien-Tzu Hsu, Chia-Ling Tu, Te-Sheng Chang, Chao-Hung Hung, Kwong-Ming Kee, Wen-Hua Chao, Sheng-Nan Lu
Community-Based Screening for Hepatitis B and C Infectivity Using Two Quantitative Antigens to Identify Endemic Townships. Viruses 14 (2) (2022)
Yung-Hsin Lu, Chung-Kuang Lu, Chun-Hsien Chen, Yung-Yu Hsieh, Shui-Yi Tung, Yi-Hsing Chen, Chih-Wei Yen, Wei-Lin Tung, Kao-Chi Chang, Wei-Ming Chen, Sheng-Nan Lu, Chao-Hung Hung, Te-Sheng Chang
Comparison of 8- versus 12-weeks of glecaprevir/pibrentasvir for Taiwanese patients with hepatitis C and compensated cirrhosis in a real-world setting. PloS one 17 (8) (2022)
Te-Sheng Chang, Nien-Tzu Hsu, Shu-Chuan Chen, I-Lin Hsu, Mei-Hsuan Lee, Sheng-Nan Lu
Non-B, Non-C Hepatocellular Carcinoma in an HBV- and HCV-Endemic Area: A Community-Based Prospective Longitudinal Study. Viruses 14 (5) (2022)
Mai-Huong T Ngo, Sue-Wei Peng, Yung-Che Kuo, Chung-Yen Lin, Ming-Heng Wu, Chia-Hsien Chuang, Cheng-Xiang Kao, Han-Yin Jeng, Gee-Way Lin, Thai-Yen Ling, Te-Sheng Chang, Yen-Hua Huang
A Yes-Associated Protein (YAP) and Insulin-Like Growth Factor 1 Receptor (IGF-1R) Signaling Loop Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma. Cancers 13 (15) (2021)
Mai-Huong Thi Ngo, Han-Yin Jeng, Yung-Che Kuo, Josephine Diony Nanda, Ageng Brahmadhi, Thai-Yen Ling, Te-Sheng Chang, Yen-Hua Huang
The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug Resistance. International journal of molecular sciences 22 (4) (2021)
Te-Sheng Chang, Kao-Chi Chang, Wei-Ming Chen, Nien-Tzu Hsu, Chih-Yi Lee, Yu-Chih Lin, Wei-Cheng Huang, Wen-Nan Chiu, Jin-Hung Hu, Tung-Jung Huang, Mei-Yen Chen, Sheng-Nan Lu
Village-to-village screening for hepatitis B and C using quantitative HBsAg and anti-HCV testing with reflex HCV core antigen tests in the remote communities of a resource-rich setting: a population-based prospective cohort study. BMJ open 11 (7) (2021)
Yuan-Jie Ding, Chung-Kuang Lu, Wei-Ming Chen, Shui-Yi Tung, Kuo-Liang Wei, Chen-Heng Shen, Yung-Yu Hsieh, Chih-Wei Yen, Kao-Chi Chang, Wen-Nan Chiu, Chao-Hung Hung, Sheng-Nan Lu, Te-Sheng Chang
Pangenotypic direct-acting antiviral agents for mixed genotype hepatitis C infection: A real-world effectiveness analysis. Journal of gastroenterology and hepatology 36 (10) (2021)
Chao-Yuan Weng, Cheng-Xiang Kao, Te-Sheng Chang, Yen-Hua Huang
Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance. International journal of molecular sciences 22 (3) (2021)
Te-Sheng Chang, Chung-Kuang Lu, Yung-Yu Hsieh, Kuo-Liang Wei, Wei-Ming Chen, Sui-Yi Tung, Cheng-Shyong Wu, Michael Wing-Yan Chan, Ming-Ko Chiang
2,4-Diamino-Quinazoline, a Wnt Signaling Inhibitor, Suppresses Gastric Cancer Progression and Metastasis. International journal of molecular sciences 21 (16) (2020)
Wen-Nan Chiu, Chao-Hung Hung, Sheng-Nan Lu, Mei-Yen Chen, Shui-Yi Tung, Kuo-Liang Wei, Chung-Kuang Lu, Chien-Hung Chen, Tsung-Hui Hu, Jin-Hung Hu, Wei-Ming Chen, Te-Sheng Chang
Real-world effectiveness of glecaprevir/pibrentasvir and ledipasvir/sofosbuvir for mixed genotype hepatitis C infection: A multicenter pooled analysis in Taiwan. Journal of viral hepatitis 27 (9) (2020)